Contrast Enhancement in Magnetic Resonance Imaging

8 clinical trials · Condition

Record	Firm	Date
A Study to Evaluate the Pharmacokinetics (How it Moves Into, Through and Out From the Body) of a New Gadolinium-based Contrast Agent (GBCA) After Injection and How Safe it is in Participants With Normal and Impaired Renal Function (NCT05061979)	Bayer	2021-10-12
A Study to Learn More About the Safety and the Level of BAY 1747846 in Body Given as Injection Into the Vein at Increasing Single Doses in Japanese Healthy Male Participants (NCT06125366)	Bayer	2019-04-17

Every clearance here is in the API, with alerts when new ones post.